Article Text

Download PDFPDF
Braking the cell’s cycle and invigorating T-cell immunity against pancreatic cancer

Statistics from Altmetric.com

Footnotes

  • Twitter @LesinskiLab

  • Contributors GBL wrote the manuscript.

  • Funding This study was supported by National Institutes of Health (NIH) grants R01CA208253, R01CA228406 and P30CA138292. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

  • Competing interests GBL has consulted for ProDa Biotech, LLC, and received compensation. The terms of this arrangement have been reviewed and approved by Emory University in accordance with its conflict of interest policies. GBL has received research funding through a sponsored research agreement between Emory University and Merck and Co, Bristol-Myers Squibb, Boerhinger-Ingelheim and Vaccinex.

  • Patient and public involvement Patients and/or the public were not involved in the design, conduct, reporting or dissemination plans of this research.

  • Patient consent for publication Not required.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles